mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.003 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.004 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |